An AI-powered clinical decision support system designed for resource-limited healthcare settings has achieved one of the highest levels of European regulatory approval, marking a significant milestone for comprehensive artificial intelligence platforms in primary care delivery.

Qure.ai announced that its Aira clinical decision support system has received Class IIb CE certification under the European Union Medical Device Regulation (EU MDR), positioning it among the world's first AI-powered platforms to combine documentation, workflow automation, electronic health record data analysis, and clinical decision-making under a single CE mark. The certification represents one of the most stringent levels of regulatory scrutiny for clinical decision support software in the European regulatory framework.

Real-World Performance Data Drives Regulatory Success

The certification follows a year of deployment across ten pilot sites in Nigeria, Kenya, Mozambique, Solomon Islands, and Bangladesh, where the system has reached thousands of patients since its 2024 launch at the World Health Assembly. Early performance data from these implementations provided evidence supporting the regulatory submission.

In Kenya, the platform demonstrated a 32% reduction in protocol-driven documentation time while maintaining a 98% documentation completion rate. Nigerian pilot sites reported a 67% improvement in the ratio of clinical-to-administrative time, favoring patient-facing activities, alongside a 23% reduction in overall administrative burden.

The system has been deployed through partnerships with organizations including the Catholic Caritas Foundation of Nigeria, Kenya Ministry of Health, Mozambique Ministry of Health via its AlôVida platform, and the WHO Western Pacific Regional Office. Clinical applications span HIV/ART care, pandemic preparedness, and general primary care with guideline-based decision support.

Addressing Primary Care Workforce Shortages Through Automation

Aira targets critical challenges in primary care delivery by standardizing adherence to clinical guidelines while reducing the administrative burden that diverts healthcare workers from patient care. The platform includes automated patient engagement features such as appointment reminders and follow-up calls delivered in local languages, including Hausa and English.

According to Prashant Warier, Co-founder and CEO of Qure.ai, the certification validates the platform's approach to addressing workforce shortages in resource-constrained settings. The system is designed to function in low-connectivity environments and integrate with existing health information systems, reducing the risk of creating parallel digital infrastructure that could fragment care delivery.

Regulatory Benchmark for Comprehensive AI Clinical Systems

The Class IIb certification establishes a regulatory precedent for AI platforms that integrate multiple clinical functions under a single approval, rather than seeking separate certifications for individual components. This comprehensive approach may influence how health ministries and procurement agencies evaluate similar systems requiring internationally recognized certification.

Qure.ai's broader AI portfolio has been deployed across more than 105 countries, with 26+ FDA-cleared findings and CE marking for over 60 indications, primarily in diagnostic imaging. The Aira certification represents the company's expansion from diagnostic AI into primary care workflow transformation and clinical decision support.

The platform's focus on chronic disease management, particularly HIV care where patient retention is critical for outcomes, addresses a documented gap in continuity of care in resource-limited settings where loss to follow-up remains a significant challenge.

Sources

  1. Qure.ai's Clinical Decision Support System Aira Among World's First to Win Class IIb CE Certification — CXOToday